FGF2 and thyroid gland carcinoma: In thyroid cancer, lncRNA MALAT1-mediated fibroblast growth factor-2 (FGF2) secretion from TAMs depresses release of inflammatory cytokines, induces vasculature formation and accelerates proliferation, invasion and migration of tumor cells [42].